期刊名称：PEDIATRIC BLOOD & CANCER
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Pediatric Blood & Cancer will publish in print and online, the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
Instructions to Authors
Wiley's Journal Styles and EndNote
Submission and Contact Information
Pediatric Blood & Cancer welcomes submitted manuscripts online at: http://mc.manuscriptcentral.com/pbc.
When uploading the manuscript files into the journal's online program, each table and each figure should be in a separate file. Tables and figures should not be in the same file as the manuscript text. See also Figures (below) for specifications.
The total number of words in the text and number of figures and tables should be listed at the bottom of the title page.
Authors are encouraged to check for an existing account. If you are submitting for the first time, and you do not have an existing account, then create a new account. Once you have logged in, you will be presented with the Main Menu and a link to your Author Center. Enter your Author Center to submit your manuscript. At the end of a successful submission, a confirmation screen with manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and/or contact our Help Desk at edsupport@wiley.com.
Editorial Office: Robert J. Arceci, M.D., Ph.D., Editor-in-Chief, Pediatric Blood & Cancer, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 2M51, Baltimore, MD 21231; Tel: 410-502-7756; Fax: 410-502-7223; E-mail: arcecro@jhmi.edu.
Submission Requirements
All manuscripts submitted to Pediatric Blood & Cancer must be submitted solely to this journal, may not have been published in any part or form in another publication of any type, professional or lay, and become the property of the publisher. Any material reproduced or adapted from any other published or unpublished source must be duly acknowledged. It is the author's responsibility to obtain permission to reproduce copyrighted material. Upon acceptance of a manuscript for publication, the author will be requested to sign an agreement transferring copyright to the publisher, who reserves copyright. Material published in this journal may not be reproduced or published elsewhere without the written permission of the publisher and the author. All statements in, or omissions from, published manuscripts are the responsibility of the author who will assist the editor and publisher by reviewing proofs. No page charges will be levied against authors or their institutions for publication in this journal.
All authors should have contributed in a significant manner and be in agreement with all content in a manuscript. The corresponding author will take responsibility for this requirement being met.
DISCLOSURE STATEMENT. All authors must disclose any affiliations that they consider to be relevant and important with any organization that to any author's knowledge has a direct interest, particularly a financial interest, in the subject matter discussed. Such affiliations inlcude, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with a company or its products. Other areas of real or perceived conflict of interest would include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations. This requirement will apply to every sort of article submitted to the Journal, including original research, reviews, editorials, letters to the editor, and any others, and should be disclosed at the time of submission. The simplest remedy for conflict of interest is disclosure. In the Journal, disclosure will henceforth be achieved by the inclusion of a short footnote with each published article. This information will be held in confidence while the paper is under review. It will not be shared with peer reviewers, and it will not influence the editorial decision to accept or reject the manuscript. When an article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be presented.
ARTICLES. Articles should represent original and in-depth studies involving all aspects of clinical or laboratory investigations. While there is no length restriction for articles, authors are encouraged to limit the text to less than 4,000 words and references to less than 50. The number of illustrations and tables should be appropriate for the data presented, but not repetitive of information in the text. Title Page. This should contain the complete title of the manuscript, names, degrees, and affiliations of all authors, the institution at which the work was performed, the name, address, telephone, E-mail, and fax numbers of the person to whom all correspondence should be addressed. The number of co-authors will be limited to six without the need to provide documentation of the time and effort expended by each. While the number of authors should usually not exceed six, exceptions will be granted with adequate justification.
A short running title of not more than 45 characters, and a list of three to six key words or phrases that will adequately index the content of the article should be provided on the title page.
Abstract. This should be a summary in not more than 250 words, and organized under headings as follows: Background (to include purpose of the work being reported); Procedure (to include materials and methods); Results; and Conclusions. Do not include material in the abstract that is not described in the body of the manuscript. Text. The text should follow the format: Introduction, Methods, Results, and Discussion. Place Acknowledgments as the last element of text, before references. Use subheadings and paragraph titles whenever possible. Authors whose first language is not English should arrange for their manuscripts to be written in idiomatic English and reviewed prior to submission by an editor facile in medical English. This will avoid disappointing delays before a paper can be sent out for review. Either American or British style is acceptable. For the former consult Merriam-Webster's; for the latter, consult the Oxford Shorter Dictionary. Abbreviations should follow the guidelines in the CBE Style Manual, 5th Edition (available from the Council of Biology Editors, Inc., One Illinois Center, Suite 200, 111 East Wacker Drive, Chicago, IL 60601-4298). All measurements must be in metric units.
Patients should be referred to only by subject numbers and not with names, initials, or other potentially identifying characters. Manuscripts reporting the results of experimental investigations on human subjects must include a statement to the effect that procedures had received official institutional approval.
Use uncapitalized generic names (e.g., cyclophosphamide) for all drugs and pharmaceutical preparations. Trade names (capitalized) for appliances, etc., may be used in the Methods section, and the manufacturers identified by name and address.
Any Tables submitted with the text should be sent/uploaded as separate Word files.
References. Authors are responsible for the accuracy of references. In the text, cite references consecutively as numerals in brackets; all references must be cited in either text or tables. Abstracts, unpublished data, and personal communications should not be listed as references. Arrange the references in numerical order, and include the names of all authors up to four in number. If more than four, list the first three followed by "et al." The complete title of the article cited and inclusive page numbers follow. Abbreviate journal names according to Index Medicus. In the following examples, notice the punctuation and order of information, do not use all capitals, do not underline:
Journal articles:
1. Nathan PC, Maze R, Spiegler B, et al. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation. Pediatr Blood Cancer 2004:42:24-29.
Books:
2. Bricker JT, Green DM, D'Angio GJ, editors. Cardiac toxicity after treatment for childhood cancer. New York: Wiley-Liss, Inc.; 1993. 1223 p.
Articles in Books:
3. Gerber JE. The role of genetic counseling in the management of long-term survivors of childhood cancer. In: Bricker JT, Green DM, D'Angio GJ, editors. Cardiac toxicity after treatment for childhood cancer. New York: Wiley-Liss, Inc.; 1993. p 121-150.
Wiley's Journal Styles are Now in Endnote: EndNote is a software product that we recommend to our journal authors to help simplify and streamline the research process. Using EndNote's bibliographic management tools, you can search bibliographic databases, build and organize your reference colletion, and then instantly output your bibliography in any Wiley reference style. Download Reference Style for this Journal: If you already use EndNote, you can download the reference style for this journal.
How to Order: To learn more about EndNote, or to purchase your own copy, click here.
Technical Support: If you need assistance using EndNote, contact endnote@isiresearchsoft.com, or visit www.endnote.com/support.
MANUSCRIPT: For optimal production, prepare manuscript text in size 12 font on 8-1/2 x 11 inch page, with at least 1 inch margins on all sides.
Figures: When preparing digital art, please submit your figures and tables as separate files and consider the following:
Resolution:
The minimum requirements for resolution are:
- 1200 DPI/PPI for black and white images, such as line drawings or graphs.
- 300 DPI/PPI for picture-only photographs
- 600 DPI/PPI for photographs containing pictures and line elements, i.e., text labels, thin lines, arrows.
These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly.
Formats:
For the entire submission/acceptance process, EPS or TIFF files will be required. For the editorial review process, color images may be submitted in RGB color; upon acceptance, CMYK color will be required. Delivery of production-quality files early in the review process may facilitate smooth and rapid publication once a manuscript has been accepted.
Legends should be placed at the end of the manuscript text file or below each figure. Please be sure to submit your figures and tables as separate files. Tables are to be numbered in order with Roman numerals, figures in Arabic.
All color figures will be reproduced in full color in the online edition of the journal at no cost to authors. Authors are requested to pay the cost of reproducing color figures in print. Authors are encouraged to submit color illustrations that highlight the text and convey essential scientific information. For best reproduction, bright, clear colors should be used. Dark colors against a dark background do not reproduce well; please place your color images against a white background wherever possible. Please contact Jessica Rodwick at 201-748-6670/jrodwick@wiley.com for further information.
A legend must be provided for each illustration and must define all abbreviations used therein.
BRIEF REPORTS. Brief reports may include descriptions of single or several patients that demonstrate novel findings or add in a significant way to already existing literature. Brief reports may also include novel laboratory observations relating to clinical questions or advances in laboratory methodologies. Text should begin with an abstract of 100 words or less that does not include headings, and be followed by a brief introduction. Total text length should be less than 1500 words and contain no more than 20 references. There should be no more than 2 illustrations and/or tables combined.
CRITICAL REVIEWS. Reviews of important and timely subjects can be invited through the editorial board or submitted independently. In the latter case, it is usually helpful for the corresponding author to consult the Editor-in-Chief prior to submission. Reviews should focus on the critical aspects of a subject, linking what is know to what areas remain controversial or unanswered. Historical accounts of important events relating to pediatric hematology/oncology are also acceptable. Reviews should normally be less than 4,000 words, contain an unstructured abstract of 100 words or less, and fewer than 100 references; illustrations and tables should be used only to provide summaries or a synthesis of ideas and/or data not also included in the text.
REVIEWS OF BOOKS AND OTHER MEDIA FORMATS. Reviews of books, films or other media formats relevant to the scientific or clinical practice of medicine with particular importance to pediatric hematology/oncology can be invited or submitted independently. In the latter case, consultation with the Editor-in-Chief should be made prior to submission.
CORRESPONDENCE AND LETTERS TO THE EDITOR. Letters to the Editor should usually be in reference to previously published manuscripts in Pediatric Blood and Cancer. However, correspondence relating to important and timely publications or topics from other sources may also be appropriate. Brief descriptions of interesting laboratory or clinical observations may also be appropriate. The length of Letters to the Editor should be less than 500 words and should contain references and illustrations or tables only when absolutely necessary.
COMMENTARY. Commentaries are usually invited but may be submitted independently after consultation with the Editor-in-Chief. Please limit the text to 2,500 words and fewer than 10 references. Commentaries should focus on a controversial subject arising from a recently published Pediatric Blood & Cancer manuscript but may also focus on independent and timely topics of relevance to the journal抯 readership. Illustrations and Tables are allowed only if they highlight or clarify points made in the text. Commentaries will be reviewed and may require changes or be rejected.
MEETING REPORTS AND SUPPLEMENTS. Concise summaries of meetings that have important information to convey to the readers of Pediatric Blood & Cancer are welcomed but consultation with the Editor-in-Chief should occur before submission. Summaries should emphasize the issues discussed at the meeting along with why they are important or controversial. Summaries should be less than 2000 words of text. Illustrations and tables can be included but only when they significantly add to the text content. More extensive meeting reports with manuscripts from the speakers at the meeting are also welcomed but early consultation with the Editor-in-Chief must take place in order to determine the type and number of manuscripts, expected pages to be published, the review process as well as procurement of additional funding if required.
TEACHING ROUNDS. This one page feature should include difficult and instructive cases with distinctive clinical, imaging or pathologic characteristics. A brief introductory paragraph of a case would be followed by the morphologic findings followed by the answer and a concluding paragraph putting the observation in perspective. No more than six references would be allowed.
CLINICAL PATHOLOGICAL PRESENTATIONS (CPCs). The CPC will cover a particularly interesting and instructive case discussion including a history of the present illness, relevant past medical, family and social history, important physical findings, imaging, pathologic diagnostic findings and a discussion of the treatment, treatment options and any other important and relevant clinical or laboratory information.
??? Production Questions ???
Jessica Rodwick
Tel.: 201-748-6670
Fax: 201-748-6825
E-mail: jrodwick@wiley.com
Editorial Board
Editor-in-Chief
Robert J. Areci, M.D., Ph.D.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland
Associate Editors
George Buchanan
University of Texas Southwestern Medical Center, Dallas, Texas Peter Newburger
University of Massachusetts Medical School, Worcester, Massachusetts
Paula Bolton-Maggs
Manchester Haemophilia Comprehensive Care Centre, Manchester,
United Kingdom Louise Parker
Sir James Spence Institute of Child Health, Newcastle Upon Tyne,
United Kingdom
Max Coppes
Alberta Children’s Hospital, Calgary, Alberta, Canada Giorgio Perilongo
University Hospital, Padova, Italy
R. Maarten Egeler
Leiden University Medical Center, Leiden, The Netherlands Kathy Pritchard-Jones
Institute of Cancer Research, Sutton, Surrey, United Kingdom
Beverly Lange
Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Yaddanapudi Ravindranath
Children’s Hospital of Michigan, Detroit, Michigan
Jeffrey Lipton
Schneider Children’s Hospital, New Hyde Park, New York Russell Ware
St. Jude Children’s Research Hospital, Memphis, Tennessee
Special Feature Editors
Controversies
Bertil Glader, Stanford, California Biological Basis of Cancer and Blood Disorders
Stella Davies, Cincinnati, Ohio
Julie Ross, Minneapolis, Minnesota Clinical Pathological Conferences
Frederic Askin, Baltimore, Maryland
Dietmar Schmidt, Mannheim, Germany
Editorial Board
Peter Adamson, Philadephia, Pennsylvania F. Leonard Johnson, Portland, Oregon
Bharat Agarwal, Bombay, India Paul Imbach, Basel, Switzerland
Todd Alonzo, Arcadia, California Csongar Kiss, Debrecen, Hungary
Peter Ambros, Vienna, Austria Heinrich Kovar, Vienna, Austra
Maurizo Arico , Palermo, Italy Larry Kun, Memphis, Tennessee
Daniel Aronson, Amsterdam, The Netherlands Lyden, David, New York, New York
Archie Bleyer, Houston, Texas Crystal Mackall, Bethesda, Maryland
Andrea Biondi, Monza, Italy John Maris, Philadelphia, Pennsylvania
Joachim Boos, Münster, Germany Helene Martelli, Paris, France
Laurence Boxer, Ann Arbor, Michigan Giuseppe Masera, Monza, Italy
Bruce Broecker, Atlanta, Georgia Katherine Matthay, San Francisco, California
Huib Caron, Amsterdam, The Netherlands Akira Nakagawara, Chiba, Japan
Donna Neuberg, Boston, Massachusetts
William Carroll, New York, New York Ellis Neufeld, Boston, Massachusetts
Luis Castillo, Montevideo, Uruguay Steve Piantadosi, Baltimore, Maryland
Alan Craft, Newcastle Upon Tyne, United Kingdom Rob Pieters, Rotterdam, The Netherlands
Ursula Creutzig, Münster, Germany Ian Pollack, Pittsburgh, Pennsylvania
Beatriz de Camargo, Sao Paulo, Brazil Jon Pritchard, Edinburgh, United Kingdom
Florent de Vathaire, Villejuif, France Gregory Reaman, Washington, D.C.
Tim Eden, Manchester, United Kingdom Jörg Ritter, Münster, Germany
Didier Frappaz, Lyon, France Leslie Robison, Memphis, Tennessee
Carolyn Felix, Philadelphia, Pennsylvania Stephen Sallan, Boston, Massachusetts
James Feusner, Oakland, California Cindy Schwartz, Baltimore, Maryland
Carolyn Freeman, Montreal, Quebec, Canada Donald Small, Baltimore, Maryland
Norbert Graf, Homburg, Germany Malcolm Smith, Rockville, Maryland
Daniel Green, Buffalo, New York
Jan-Inge Henter, Stockholm, Sweden Rogier Versteeg, Amsterdam, The Netherlands
Melissa Hudson, Memphis, Tennessee Winfred Wang, Memphis, Tennessee
Meriel Jenney, Cardiff, United Kingdom
Editorial Manager
Martha Merrell
EDITOR-IN-CHIEF
Robert J. Arceci, M.D., Ph.D.
Director and King Fahd Professor of Pediatric Oncology, Professor of Pediatrics and Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
Publications Committee
F. Leonard Johnson
Oregon Health & Science University,
Portland, Oregon
Secretary Daniel Aronson
Academic Medical Centre
Amsterdam, The Netherlands
Tim Eden
The Christie Hospital N.H.S. Trust
Manchester, United Kingdom
International Society of Pediatric Oncology (SIOP)
President Tim Eden
The Christie Hospital N.H.S. Trust
Manchester, United Kingdom
Laurence Boxer
University of Michigan School of Medicine
Ann Arbor, Michigan Secretary-General Daniel Green
Roswell Park Cancer Institute
Buffalo, New York
Daniel Green
Roswell Park Cancer Institute
Buffalo, New York Chairman, Scientific Committee
Dr. Giorgio Perilongo
University of Padova
Padova, Italy
The American Society of Pediatric Hematology/Oncology (ASPHO)
President F. Leonard Johnson
Oregon Health & Science University
Portland, Oregon Continental Presidents
Africa
Prof. Fouzia Msefer Alaoui
Hospital d?Enfants de Rabat
Rabat, Morocco
Vice President William Woods
AFLAC Cancer Center & Blood Disorders
Atlanta, Georgia Asia
Dr. Yao-Ping Wang
Shanghai Institute of Pediatric Hematology Oncology
Shanghai, China
Secretary-Treasurer Jeffrey Lipton
Schneider Children’s Hospital
New Hyde Park, New York South America
Beatriz de Camargo
Hospital do Cancer
Sao Paulo, Brazil
North America
Yaddanapudi Ravindranath
Children’s Hospital of Michigan
Detroit, Michigan
Histiocyte Society
President- Jan-Inge Henter
Karolinska Hospital
Stockholm, Sweden
Europe
Günter H.R. Henze
Charite?Campus Virchowklinikum
Berlin, Germany
Secretary Alexandra Filipovich
Children’s Hospital Medical Center
Cincinnati, Ohio Oceania/Australasia
Keith Waters
Royal Children’s Hospital
Parkville, Victoria, Australia
International Society of Paediatric Surgical Oncology (IPSO)
President- Hélene Martelli
Hospital de Bicetre
Le Kremlin-Bicetre France
|
